Louis Jozef Elisabeth Van Der Veken, based in Vosselaar, Belgium, is a notable inventor with an impressive portfolio of 20 patents. His contributions primarily lie in the field of pharmaceuticals, particularly in developing compounds that serve as inhibitors in various biological processes.

Latest Patents

Among Van Der Veken's most recent innovations are patents that focus on Pyrrolidin-2-one and piperidin-2-one derivatives, specifically as 11-beta hydroxysteroid dehydrogenase inhibitors. These patents detail the N-oxide forms, pharmaceutically acceptable addition salts, and their stereochemically isomeric forms. Additionally, he has worked on tricyclic lactam derivatives which also act as 11-beta hydroxysteroid dehydrogenase inhibitors, showcasing his dedication to advancing therapeutic options in this domain.

Career Highlights

Throughout his career, Van Der Veken has made significant strides in pharmaceutical research. He has been affiliated with Janssen Pharmaceutica NV, a leading company in the development of innovative pharmaceutical products. His work here and in other roles has contributed to enhancing drug efficacy and safety.

Collaborations

Van Der Veken has collaborated with other prominent professionals in the field, including Joannes Theodorus Maria Linders and Libuse Jaroskova. These partnerships have enabled him to leverage diverse expertise and drive innovation further in his research endeavors.

Conclusion

Louis Jozef Elisabeth Van Der Veken's relentless pursuit of innovation in the pharmaceutical sector has led to the development of several impactful patents. His work not only exemplifies individual achievement in invention but also highlights the importance of collaboration in fostering advancements in science and medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com